The fourth session was focused on bringing researchers and clinicians together to discuss current treatment, clinical trials, and studies into illicit drug use.
The session included presentations on the latest trends in illicit drug use, including NDARC's clinical trials, with a particular focus on opioids and methamphetamine.
Session Chair: Dr Fadil Pedic
| Title | Presenter | Presentation type |
|
Welcome to Country |
|
|
| Mind the gap - between research and clinical outcomes. ABSTRACT. |
Dr James Bell |
Presentation |
|
Evaluating outcomes, processes and costs of depot buprenorphine – the CoLAB study. ABSTRACT. |
Professor Michael Farrell, Director of NDARC |
Presentation |
|
Discussion (inc. Q&A) |
|
Discussion (inc. Q&A) |
|
Change in opioid agonist treatment retention with buprenorphine versus methadone: A 15-year longitudinal cohort study of new entrants. WATCH HERE. |
Ms Chrianna Bharat, Research Fellow at NDARC |
Featured Poster |
|
Health service utilisation by people living with chronic non-cancer pain whilst using opioids: A 5-year prospective observational study. WATCH HERE. |
Ms Ria Hopkins, Doctoral Candidate at NDARC |
Featured Poster |
|
Optimising care for people who inject drugs: A mixed methods analysis of discharge against medical advice (DAMA) and incomplete treatment for people who inject drugs. WATCH HERE. |
Mr Liam Acheson, Doctoral Candidate at NDARC |
Featured Poster |
|
Injecting-related injuries and diseases among a sample of people who inject drugs in Australia. WATCH HERE. |
Ms Samantha Colledge, Research Assistant at NDARC |
Featured Poster |
|
Estimating the prevalence of childhood maltreatment in people with opioid dependence: A systematic review and meta-analysis. WACTH HERE. |
Mr Thomas Santo Jr., Research Officer at NDARC |
Featured Poster |
|
Do cryptomarkets users differ in reporting emergency medical treatment following MDMA, LSD and cocaine use? WATCH HERE. |
Mr Leigh Coney, Doctoral Candidate at NDARC |
Featured Poster |
|
Trends in methamphetamine availability, use, and harms in Australia. WATCH HERE. |
Dr Nicola Man, Research Fellow at NDARC |
Featured Poster |
|
NCCRED- Bringing researchers and clinicians together - highlight on methamphetamine. ABSTRACT. |
Dr Nadine Ezard, Director of the National Centre for Clinical Research on Emerging Drugs (NCCRED) |
Presentation |
|
Findings from the N-ICE trial: A randomised double-blind placebo-controlled study of the safety and efficacy of N-acetyl-cysteine (NAC) as a pharmacotherapy for methamphetamine (“ice”) dependence. ABSTRACT. |
Associate Professor Rebecca McKetin, Associate Professor at NDARC |
Presentation |
|
Discussion (inc. Q&A) |
|
Discussion (inc. Q&A) |
|
Poster winner announcement Wrap up and close |
Professor Michael Farrell, Director at NDARC |
|
Chair:
Dr Fadil Pedic
Dr Fadil Pedic is Manager, Strategic Research & Evaluation, Centre for Alcohol and Other Drugs at the NSW Ministry of Health.
Fadil has worked at both Federal and NSW Health departments, founded two research agencies, and headed up the Government and Social Research divisions at two other agencies.
His research is centred around behaviour change, social issues and health promotion on topics as varied as: drug use in prisons, children’s obesity, tobacco cessation, apprenticeship retention, and cyber-safety.
Presenters:
Dr James Bell
James Bell, BA, MBBS, FRACP, FAChAM, MD, is a physician who has worked in Addiction Medicine in the UK and Australia. He developed training programs for doctors in Australia and the UK. He was a leading figure in establishing the Chapter of Addiction Medicine and having Addiction Medicine recognised as a speciality in Australia. His major research interest is the treatment of addictive disorders, and he has published extensively on treatment of opioid dependence.
Professor Michael Farrell
Professor Michael Farrell FRCP FRCPsych is the Director of NDARC since 2011. Before that he was Professor of Addiction Psychiatry at the Institute of Psychiatry at Kings College London. His extensive research interests include treatment evaluation, national and international drug policy. He is the Chair of the International Consortium on Health Outcome Monitoring Substance Use working Group and Editor of the Cochrane Drug and Alcohol Group. He has a long-standing interest in drug dependence, comorbidity and drugs in the wider criminal justice system. He has been a member of the WHO Expert Committee on Drug and Alcohol Dependence since 1995.
Dr Nadine Ezard
Conjoint Professor Nadine Ezard is the Director of NCCRED. Nadine is also the Clinical Director of the Alcohol and Drug Service at St Vincent’s Hospital, Sydney Australia home to one of NSW’s first specialist stimulant treatment programs.
Associate Professor Rebecca McKetin
A/Prof Rebecca McKetin (BSc(Psychol)Hons. PhD) leads a program of research into stimulant use epidemiology and interventions at the National Drug and Alcohol Research Centre, UNSW. Her current research involves the online delivery of psychological help for people who use stimulants (www.breakingtheice.org), the trialling of new pharmacotherapy options for methamphetamine dependence (www.nicetrial.info; www.limastudy.info) and the development of novel responses to methamphetamine use in Aboriginal and Torres Strait Islander communities (http://nimac.org.au/).
All posters this year can be accessed online and are accomnaied by a two minute presentation.